TLR7 and psoriasis: In an imiquimod (IMQ), a toll-like receptor 7 (TLR7) agonist, induced mouse model of psoriasis, S1P exhibited anti-proliferative effects on dermal cells and anti-inflammatory effects by preventing immune cell, particularly DC, infiltration [14].